FI956074A0 - Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia - Google Patents

Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia

Info

Publication number
FI956074A0
FI956074A0 FI956074A FI956074A FI956074A0 FI 956074 A0 FI956074 A0 FI 956074A0 FI 956074 A FI956074 A FI 956074A FI 956074 A FI956074 A FI 956074A FI 956074 A0 FI956074 A0 FI 956074A0
Authority
FI
Finland
Prior art keywords
oxidol
derivatives
acetylcholinesterase inhibitors
substituted isatin
isatin
Prior art date
Application number
FI956074A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI956074A (fi
Inventor
Bernard Robin Boar
Dennis Mark O'shea
Ian David Tomlinson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI956074A publication Critical patent/FI956074A/fi
Publication of FI956074A0 publication Critical patent/FI956074A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI956074A 1993-06-16 1995-12-18 Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia FI956074A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302080A SE9302080D0 (sv) 1993-06-16 1993-06-16 New compounds
PCT/SE1994/000448 WO1994029272A1 (fr) 1993-06-16 1994-05-13 Derives de l'isatine a substitution 1 et de l'oxindole utiles comme inhibiteurs de l'acetylcholinesterase

Publications (2)

Publication Number Publication Date
FI956074A FI956074A (fi) 1995-12-18
FI956074A0 true FI956074A0 (fi) 1995-12-18

Family

ID=20390305

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956074A FI956074A0 (fi) 1993-06-16 1995-12-18 Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia

Country Status (9)

Country Link
EP (1) EP0703901A1 (fr)
JP (1) JPH08511515A (fr)
AU (1) AU7010894A (fr)
CA (1) CA2164119A1 (fr)
FI (1) FI956074A0 (fr)
IS (1) IS4167A (fr)
NO (1) NO955074L (fr)
SE (1) SE9302080D0 (fr)
WO (1) WO1994029272A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103752D0 (sv) * 1991-12-18 1991-12-18 Astra Ab New compounds
ATE249828T1 (de) 1998-03-06 2003-10-15 Astrazeneca Ab Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
CN1572299A (zh) 1998-09-30 2005-02-02 武田药品工业株式会社 改善膀胱排泄能力的药物
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
WO2002070478A1 (fr) 2001-03-06 2002-09-12 Astrazeneca Ab Dérivés indolone capable de dégrader des vaisseaux
TW200508197A (en) 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
ATE440826T1 (de) * 2004-05-27 2009-09-15 Ucb Pharma Sa Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen
ATE482194T1 (de) * 2004-07-22 2010-10-15 Ucb Pharma Sa Indolonderivate, verfahren zu deren herstellung und deren anwendungen
GT200500185A (es) 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
WO2010090680A1 (fr) * 2008-12-15 2010-08-12 Wyeth Llc Agonistes de cb2 de type oxindole substitué
CN109662964A (zh) 2010-02-09 2019-04-23 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
CA2891122C (fr) 2012-11-14 2021-07-20 The Johns Hopkins University Methodes et compositions pour le traitement de la schizophrenie
AU2013357308B2 (en) 2012-12-13 2017-08-31 H. Lundbeck A/S Compositions comprising vortioxetine and donepezil
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
CN103242332B (zh) * 2013-05-13 2015-11-04 江西科技师范大学 1-n酰基取代吲哚酮衍生物
CN104530065A (zh) * 2013-05-13 2015-04-22 江西科技师范大学 1-n酰基取代吲哚酮衍生物的应用
CA2986598C (fr) 2015-05-22 2023-09-26 Agenebio, Inc. Compositions pharmaceutiques de levetiracetam a liberation prolongee

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491106A (de) * 1964-06-11 1970-05-31 Ciba Geigy Verfahren zur Herstellung von neuen Thiosemicarbazonen

Also Published As

Publication number Publication date
JPH08511515A (ja) 1996-12-03
NO955074L (no) 1996-02-07
WO1994029272A1 (fr) 1994-12-22
CA2164119A1 (fr) 1994-12-22
EP0703901A1 (fr) 1996-04-03
FI956074A (fi) 1995-12-18
NO955074D0 (no) 1995-12-14
AU7010894A (en) 1995-01-03
IS4167A (is) 1994-12-17
SE9302080D0 (sv) 1993-06-16

Similar Documents

Publication Publication Date Title
FI956074A0 (fi) Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia
ATE225784T1 (de) Indan- oder dihydroindolderivate
NO301879B1 (no) Indol-derivater
FI962315A0 (fi) Entsyymi-inhibiittorit
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
FI944969A (fi) Indolijohdannaisia
DE69634416D1 (de) Chinolin-derivate
FI940393A0 (fi) Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina
EP0707581A1 (fr) Derives indoliniques utilises comme antagonistes de 5ht 2c?
DK0892796T3 (da) Isatinderivater som acetylcholinesteraseinhibitorer og analgetika
NO961475L (no) Indol-derivater
PL337645A1 (en) Novel amidine derivatives and their application as thrombosin inhibitors
PT934280E (pt) Derivados 2-cianoiminoimidazolo inibidores da pde iv
AU1766997A (en) Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
FI961977A (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
GB9420287D0 (en) 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase
LV11328A (lv) 1-(2-fluorciklopropil)-hinolona un naftiridonkarbonskabes atvasinajumi
DE69720957T2 (de) Ace-hemmer
DE69431454D1 (de) Amylase Inhibitoren
DE69418656D1 (de) 2-acyloxycephemderivate als elastaseinhibitoren
SI0892796T1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
DE59706183D1 (de) Tetrahydropyrimidin-derivate
NO951241D0 (no) Forbedret indolbiosyntese
ZA941092B (en) Indolin-2-one derivatives
NO934473D0 (no) N-substituerte azabicykloheptanderivater

Legal Events

Date Code Title Description
FD Application lapsed